Eric Ostertag
2022
In 2022, Eric Ostertag earned a total compensation of $1.3M as Former Executive Chairman and former Chief Executive Officer at Poseida Therapeutics, a 79% decrease compared to previous year.
Compensation breakdown
| Option Awards | $429,972 |
|---|---|
| Salary | $448,313 |
| Stock Awards | $425,125 |
| Other | $12,710 |
| Total | $1,316,120 |
Ostertag received $448.3K in salary, accounting for 34% of the total pay in 2022.
Ostertag also received $430K in option awards, $425.1K in stock awards and $12.7K in other compensation.
Rankings
In 2022, Eric Ostertag's compensation ranked 2,499th out of 5,760 executives tracked by ExecPay. In other words, Ostertag earned more than 56.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,499 out of 5,760 | 57th |
Division Manufacturing | 1,374 out of 3,136 | 56th |
Major group Chemicals And Allied Products | 621 out of 1,422 | 56th |
Industry group Drugs | 575 out of 1,323 | 57th |
Industry Biological Products, Except Diagnostic Substances | 143 out of 291 | 51st |
Source: SEC filing on April 26, 2023.
Ostertag's colleagues
We found three more compensation records of executives who worked with Eric Ostertag at Poseida Therapeutics in 2022.